Julia Lainster

The human heart remains one of the few organs incapable of mounting a successful self-repair response following a major traumatic event like a myocardial infarction. While the liver can regrow and the skin heals seamlessly, the adult mammalian heart typically responds to injury by producing stiff,

Determining the survival trajectory of a gastric cancer patient often relies on a microscopic examination of the tumor's architectural spread, yet this conventional approach frequently misses the vital physiological narrative of the host. Researchers at the State University of Campinas have

The landscape of botanical medicine underwent a massive transformation as pharmaceutical-grade cannabinoid research transitioned from niche experimentation to a cornerstone of modern therapeutic development. Ananda Pharma has positioned itself at the forefront of this evolution by announcing the

The precision required to manipulate matter at the atomic level has historically been limited by the observational lag between synthesis and characterization, but recent breakthroughs are finally closing this gap. Modern laboratories are transitioning from static imaging to dynamic, in-situ

Pancreatic cancer has remained an almost invincible adversary in the medical world, frequently defying the very treatments that have successfully tamed other aggressive forms of the disease. While oncology has celebrated remarkable progress in targeted therapies, pancreatic ductal adenocarcinoma

The systematic destruction of stationary healthcare facilities across vast stretches of Ukrainian territory has left millions of civilians without reliable access to essential life-saving medical services. Since the escalation of the conflict, more than 1,500 hospitals and clinics have sustained

The clinical landscape of hepatobiliary surgery has undergone a profound transformation as medical teams increasingly rely on high-resolution imaging to evaluate donor organs before any surgical intervention begins. For decades, the decision to accept or reject a donor liver rested on subjective

Ivan Kairatov is a seasoned Biopharma expert whose career has been defined by the pursuit of technological innovation in research and development. With a deep-seated understanding of how automated systems can transform biological monitoring, he offers a unique perspective on the digital evolution

The global pharmaceutical sector is currently undergoing a massive transformation as the industry faces the dual challenges of rising research costs and the diminishing returns of traditional screening methods. Innovations in artificial intelligence and robotics are no longer merely speculative

The traditional pharmaceutical development funnel is currently facing a massive overhaul as researchers move away from static, isolated chemical assays toward dynamic platforms that observe drug behavior within the bustling complexity of living human cells. This transition marks a fundamental